Your browser doesn't support javascript.
loading
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling.
Raudenska, Martina; Balvan, Jan; Hanelova, Klara; Bugajova, Maria; Masarik, Michal.
Affiliation
  • Raudenska M; Department of Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic.
  • Balvan J; Department of Pathological Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic.
  • Hanelova K; Department of Pathological Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic.
  • Bugajova M; Department of Pathological Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic.
  • Masarik M; Department of Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University / Kamenice 5, CZ-625 00 Brno, Czech Republic; Institute of Pathophysiology, First Faculty of Medicine, Charle
Biochim Biophys Acta Rev Cancer ; 1878(5): 188940, 2023 09.
Article de En | MEDLINE | ID: mdl-37331641
ABSTRACT
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor-permissive extracellular matrix structure, angiogenesis, or immune and metabolic reprogramming of the tumor microenvironment (TME), with implications for metastasis and resistance to radiotherapy and chemotherapy. The pleiotropic effect of CAFs in TME is likely to reflect the heterogeneity and plasticity of their population, with context-dependent effects on carcinogenesis. The specific properties of CAFs provide many targetable molecules that could play an important role in the future therapy of HNSCC. In this review article, we will focus on the role of CAFs in the TME of HNSCC tumors. We will also discuss clinically relevant agents targeting CAFs, their signals, and signaling pathways, which are activated by CAFs in cancer cells, with the potential for repurposing for HNSCC therapy.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibroblastes associés au cancer / Tumeurs de la tête et du cou Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Biochim Biophys Acta Rev Cancer Année: 2023 Type de document: Article Pays d'affiliation: République tchèque

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibroblastes associés au cancer / Tumeurs de la tête et du cou Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Biochim Biophys Acta Rev Cancer Année: 2023 Type de document: Article Pays d'affiliation: République tchèque